BACKGROUND: The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure recommends that clinicians …

Combination therapy is used to lower blood pressure in the majority of patients with
hypertension, yet there has been little evidence as to which classes of antihypertensive …

Hypertension (HTN) is a major risk factor for cardiovascular mortality, yet only a small
proportion of hypertensive individuals receive appropriate therapy and achieve target blood …

To date, a range of drugs are available that are generally well tolerated and effective in
lowering blood pressure. Although they are successful in reducing stroke, renal failure, and …

Hypertension incurs a significant healthcare burden in Asia-Pacific countries, which have
suboptimal rates of blood pressure (BP) treatment and control. A consensus meeting of …

The management of the high-risk patient with hypertension has become more challenging in
recent years. Drug therapy should be initiated earlier and at lower blood pressure levels in …

Recent hypertension guidelines recommend initiating antihypertensive therapy with a
combination of two or more agents in patients whose blood pressure exceeds their …

The clinical benefit of aggressive blood pressure (BP) control in reducing adverse
cardiovascular and renal outcomes is well documented. However, a majority of patients with …

Background: Use of drug combinations is recommended by hypertension guidelines for
most patients because of the greater blood pressure (BP)-lowering effect compared with …